Contact Us

BUSINESS NEWS

Lingnan University participates in the 2024 Academy of International Business Asia Pacific Regional Conference

Dec 18, 2024

HONG KONG,Dec. 16,2024-- The 2024 Academy of International Business (AIB) Asia Pacific Regional Conference was held from 4 to 6 December in Guangzhou. This year\'s conference,"Reimagine Internati

BRI Celebrates Its 129th Anniversary by Distributing Rp20.46 trillion Interim Dividend to Shareholders

Dec 18, 2024

JAKARTA,Indonesia,Dec. 16,2024-- PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) proudly announces the distribution of an interim dividend to shareholders as part of its 129th Anniversary celebrati

Discovering Pingshan District: A New Horizon for Global Talent

Dec 18, 2024

SHENZHEN,China,Dec. 16,2024-- This is a report from Shenzhen Daily: Every journey in life begins with a single step forward. For those seeking a vibrant future,there is an ideal destination in South C

Farasis Energy Named a Top-10 Brand in China's 2024 Solid-State Battery Competitiveness Rankings

Dec 18, 2024

GANZHOU,China,Dec. 16,2024-- The 2024 China Solid-State Battery Competitiveness Rankings were recently announced,with Farasis Energy earning a prestigious spot on the Top 10 list. Currently,Farasis En

Video: CEO presentation at Minesto's Capital Market Day 2024

Dec 18, 2024

The CEO presentation from Minesto\'s Capital Market Day is now available on the company\'s website and YouTube channel. The Capital Market Day was held on 11 December 2024 at the company\'s workshop i

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

Dec 18, 2024

– Both pivotal studies achievedprimary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies with high statistical significance (p<0.0001)

1 ... 167 168 169 170 171 172 173 ... 360